coronavirus vaccine that was approved by Moscow last month and is undergoing Phase 3 trials."It makes it possible to develop a very strong, long-lasting immunity to the specific protein of the coronavirus, i.e.
the corona protein, and hence, boost immune response, immune defense of a person by four, five, six and more times," he said.On August 11, Russia registered the world’s first vaccine against the novel coronavirus, dubbed Sputnik V.